Private Public Partnership to Fast Track Treatments for Rare Cancers Receives Backing from the Australian Government
A new multi-faceted partnership supported by George Clinical will move to the forefront of the cancer treatment revolution. The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub building links from research through to the clinic; creating jobs and changing lives. Over the past decade, immunotherapy and other …